Primary Antibiotic Resistance of Helicobacter pylori in China-Reference-Cited by-同舟云学术

Primary Antibiotic Resistance of Helicobacter pylori in China

Published:2017-03-17 Issue:5 Volume:62 Page:1146-1154
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Hu Yi,Zhu Yin,Lu Nong-hua

Funder

the National Natural Science Foundation of China

the Graduate Innovation fund of Jiangxi Province

grants from the Jiangxi Province Talent 555 Project

the National Science and Technology Major Projects for “Major New Drugs Innovation and Development” of China

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-017-4536-8.pdf

Reference70 articles.

1. Sipponen P. Natural history of gastritis and its relationship to peptic ulcer disease. Digestion. 1992;51:70–75.

2. Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64:1353–1367.

3. Graham DY. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology. 2015;148:719–731.e3.

4. Goni E, Franceschi F. Helicobacter pylori and extragastric diseases. Helicobacter. 2016;21:45–48.

5. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241.

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Comparison of the Clinical Efficacy and Drug Tissue Distribution of Furazolidone and Tetracycline-quadruple Therapy in Helicobacter pylori Eradication;Journal of Clinical Gastroenterology;2024-07-17

2. Tetracycline Three Times Daily Versus Four Times Daily in Bismuth‐Containing Quadruple Therapy as the First‐Line Treatment of Helicobacter pylori Infection: A Multicenter, Noninferiority, Randomized Controlled Trial;Helicobacter;2024-07

3. Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings;Critical Reviews in Microbiology;2024-06-24

4. An eco-friendly liquid chromatographic analysis of the triple therapy protocol of amoxicillin, metronidazole and vonoprazan for H. Pylori eradication: application to combined dosage forms and simulated gastric fluid;BMC Chemistry;2024-05-30

5. Dynamic changes in the gut microbiota after bismuth quadruple therapy and high‐dose dual therapy for Helicobacter pylori eradication;Helicobacter;2024-03